1. Home
  2. ELOG vs BCTX Comparison

ELOG vs BCTX Comparison

Compare ELOG & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELOG

Eastern International Ltd. Ordinary Shares

N/A

Current Price

$1.40

Market Cap

18.6M

Sector

Industrials

ML Signal

N/A

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.33

Market Cap

17.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELOG
BCTX
Founded
2006
2014
Country
China
Canada
Employees
N/A
N/A
Industry
Integrated Freight & Logistics
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.6M
17.0M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
ELOG
BCTX
Price
$1.40
$4.33
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
2.0M
858.8K
Earning Date
02-10-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
59.27
N/A
EPS
0.16
N/A
Revenue
$45,962,309.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$380.95
P/E Ratio
$9.10
N/A
Revenue Growth
10.64
N/A
52 Week Low
$0.88
$4.10
52 Week High
$3.60
$98.20

Technical Indicators

Market Signals
Indicator
ELOG
BCTX
Relative Strength Index (RSI) N/A 37.42
Support Level N/A $4.10
Resistance Level N/A $4.56
Average True Range (ATR) 0.00 0.71
MACD 0.00 -0.25
Stochastic Oscillator 0.00 3.12

Price Performance

Historical Comparison
ELOG
BCTX

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products. Its segments are Transportation services and Warehouse subleasing services. The group generates the majority of its revenue from Transportation services.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: